SomaLogic, Inc. (SLGC)

NASDAQ: SLGC · IEX Real-Time Price · USD
2.73
+0.02 (0.74%)
At close: Nov 27, 2023, 4:00 PM
2.71
-0.02 (-0.73%)
After-hours: Nov 27, 2023, 5:07 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
97.6781.6355.8932.19
Revenue Growth (YoY)
19.65%46.05%73.64%-
Cost of Revenue
43.3633.4622.6118.23
Gross Profit
54.348.1633.2813.96
Selling, General & Admin
156.6277.9736.8833.77
Research & Development
73.4443.530.7532.5
Operating Expenses
230.06121.4767.6366.27
Operating Income
-175.76-73.3-34.36-52.31
Interest Expense / Income
01.3218.346.23
Other Expense / Income
-65.8912.880.32-1.54
Pretax Income
-109.87-87.51-53.02-57
Income Tax
-0.720.0400
Net Income
-109.16-87.55-53.02-57
Shares Outstanding (Basic)
1841376572
Shares Outstanding (Diluted)
1841376572
Shares Change
34.15%110.49%-9.96%-
EPS (Basic)
-0.59-0.64-0.81-0.79
EPS (Diluted)
-0.59-0.64-0.81-0.79
Free Cash Flow
-105.88-43.69-29.44-51.21
Free Cash Flow Per Share
-0.57-0.32-0.45-0.71
Gross Margin
55.60%59.00%59.54%43.36%
Operating Margin
-179.96%-89.80%-61.47%-162.53%
Profit Margin
-111.77%-107.25%-94.86%-177.10%
Free Cash Flow Margin
-108.41%-53.53%-52.68%-159.09%
EBITDA
-105.3-83.62-31.85-47.62
EBITDA Margin
-107.82%-102.44%-57.00%-147.95%
Depreciation & Amortization
4.572.572.823.16
EBIT
-109.87-86.19-34.68-50.78
EBIT Margin
-112.50%-105.59%-62.05%-157.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).